跳至主要内容
临床试验/NCT00871455
NCT00871455已完成不适用

Effect of Low-Dose Baclofen Administration on the GH-IGF1 Axis Study

US Department of Veterans Affairs1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2003年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Determine the threshold dose 20 or 40 mg/d of baclofen and the dose-response curve of the medication for its effect to raise plasma IGF-1 levels

研究概览

简要总结

Insulin-like growth factor I (IGF-I) is used as a measure of the body's ability to produce growth hormone. Growth hormone is important for muscle tissue as well as many other tissues in the body. Growth hormone (GH) and IGF-I have been shown to be reduced in many persons with SCI. Baclofen is a FDA approved drug that is used to treat spasticity. Persons receiving long-term baclofen therapy have been demonstrated to have increased growth hormone and IGF-I levels. IGF-I levels will be determined before and after treatment with baclofen. In this study, the investigators will determine the minimum dose of baclofen at which improvements in GH and IGF-1 levels occur.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with chronic SCI (injury greater than 6 months) who have been screened and found to have depressed plasma IGF-1 levels and who are not taking baclofen.

排除标准

  • Acute illness of any etiology,
  • Patients with chronic renal, liver, lung, or cardiac disease,
  • Patients receiving any of the following medications: narcotics, or L-DOPA, and
  • Alcoholics.

研究组 & 干预措施

1

Experimental

Subjects will receive 20 mg baclofen for 8 weeks, followed by 40 mg baclofen for 8 weeks.

干预措施: Baclofen (Drug)

结局指标

主要结局

Determine the threshold dose 20 or 40 mg/d of baclofen and the dose-response curve of the medication for its effect to raise plasma IGF-1 levels

时间窗: 20-week (5 months) in which subjects are asked to report for 12 visits after starting baclofen therapy

次要结局

  • Assessment of the adverse side effects, if any, of low dose baclofen therapy(20-week (5 months) in which subjects are asked to report for 12 visits after starting baclofen therapy)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验